According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent of patients with multiple myeloma, a lethal form of blood cancer. Based on these encouraging findings, an application to the US Read More...
It's a good thing that the field of cancer research has so many minds hard at work, inventing ingenious methods of diagnosis, prevention, and treatment, such as non-invasive MINIMA therapy using MRI scanners, or mRNA vaccines that can carry out targeted cancer therapy. Researchers from Read More...